166 related articles for article (PubMed ID: 22920334)
21. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.
Spiess PE; Kassouf W; Brown GA; Kamat AM; Liu P; Gomez JA; Tu SM; Tannir NM; Pisters LL
J Urol; 2007 Apr; 177(4):1330-4; discussion 1334. PubMed ID: 17382725
[TBL] [Abstract][Full Text] [Related]
23. [Is organ saving surgery of testicular tumor justified?].
Weissbach L
Urologe A; 1993 Jan; 32(1):49-52. PubMed ID: 8383368
[TBL] [Abstract][Full Text] [Related]
24. Growing teratoma syndrome of the ovary: a case report with FDG-PET findings.
Kikawa S; Todo Y; Minobe S; Yamashiro K; Kato H; Sakuragi N
J Obstet Gynaecol Res; 2011 Jul; 37(7):926-32. PubMed ID: 21450035
[TBL] [Abstract][Full Text] [Related]
25. Growing teratoma syndrome in primary mediastinal germ cell tumor: our experience.
Sachdeva AK; Penumadu P; Kohli P; Dubashi B; Munuswamy H
Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):98-104. PubMed ID: 30646758
[TBL] [Abstract][Full Text] [Related]
26. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
27. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
28. Development of angiosarcoma in a mediastinal non-seminomatous germ cell tumor that exhibited growing teratoma syndrome during chemotherapy.
Matsuoka S; Koyama T; Takeda T; Yamada K; Hyogotani A; Hamanaka K; Sekiguchi N; Koizumi T
Thorac Cancer; 2019 Jan; 10(1):111-115. PubMed ID: 30407736
[TBL] [Abstract][Full Text] [Related]
29. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
30. Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
Toyoshima Y; Hara T; Matsui Y; Nagumo Y; Maejima A; Shinoda Y; Komiyama M; Watanabe SI; Fujimoto H
Ann Surg Oncol; 2018 Nov; 25(12):3668-3675. PubMed ID: 30191415
[TBL] [Abstract][Full Text] [Related]
31. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
Panicek DM; Toner GC; Heelan RT; Bosl GJ
Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
[TBL] [Abstract][Full Text] [Related]
32. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
33. [Dedifferentiation of mature teratomas secondary to testicular cancer: report of 2 cases].
Game X; Houlgatte A; Fournier R; Duhamel P; Baranger B; Khoury S
Prog Urol; 2001 Feb; 11(1):73-6; discussion 76-7. PubMed ID: 11296651
[TBL] [Abstract][Full Text] [Related]
34. Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor.
Sadeghi N; Badalato GM; Kates M; McKiernan JM
Urol Oncol; 2011; 29(6):837-41. PubMed ID: 21489835
[TBL] [Abstract][Full Text] [Related]
35. Mediastinal growing teratoma syndrome.
Afifi HY; Bosl GJ; Burt ME
Ann Thorac Surg; 1997 Aug; 64(2):359-62. PubMed ID: 9262575
[TBL] [Abstract][Full Text] [Related]
36. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party.
Stenning SP; Parkinson MC; Fisher C; Mead GM; Cook PA; Fossa SD; Horwich A; Jones WG; Newlands ES; Oliver RT; Stenwig AE; Wilkinson PM
Cancer; 1998 Oct; 83(7):1409-19. PubMed ID: 9762943
[TBL] [Abstract][Full Text] [Related]
37. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?
Aide N; Comoz F; Sevin E
J Clin Oncol; 2007 Oct; 25(28):4494-6. PubMed ID: 17906212
[No Abstract] [Full Text] [Related]
38. Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours.
Napier MP; Naraghi A; Christmas TJ; Rustin GJ
Br J Cancer; 2000 Nov; 83(10):1274-80. PubMed ID: 11044349
[TBL] [Abstract][Full Text] [Related]
39. [Growing teratoma syndrome in metastatic germinal non-seminomatous testicular tumors].
Alcaraz A; Arango O; Talbot-Wrigth R; Gelabert A; Ayuso C; Alvarez-Vijande R; Bielsa O; Vesa J; Carretero P
Actas Urol Esp; 1990; 14(3):239-42. PubMed ID: 2239407
[TBL] [Abstract][Full Text] [Related]
40. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
Kuczyk MA; Bokemeyer C; Fichna B; Truss M; Schmoll HJ; Jonas U
Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
